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Machado–Joseph disease (MJD/SCA3) is an autosomal dominant neurodegenerative disease caused by the expansion of a CAG tract in the
coding portion of the ATXN3 gene. The presence of ubiquitin-positive aggregates of the defective protein in affected neurons is characteristic of
this and most of the polyglutamine disorders. Recently, the accumulation of the neural precursor cell expressed developmentally downregulated 8
(NEDD8), a ubiquitin-like protein, in the inclusions of MJD brains was reported. Here, we report a new molecular interaction between wild-type
ataxin-3 and NEDD8, using in vitro and in situ approaches. Furthermore, we show that this interaction is not dependent on the ubiquitin-
interacting motifs in ataxin-3, since the presence of the Josephin domain is sufficient for the interaction to occur. The conservation of the
interaction between the Caenorhabditis elegans ataxin-3 homologue (atx-3) and NEDD8 suggests its biological and functional relevance.
Molecular docking studies of the NEDD8 molecule to the Josephin domain of ataxin-3 suggest that NEDD8 interacts with ataxin-3 in a substrate-
like mode. In agreement, ataxin-3 displays deneddylase activity against a fluorogenic NEDD8 substrate.
© 2007 Elsevier B.V. All rights reserved.Keywords: Polyglutamine; UBL; Ubiquitin; E3 ligase; Neurodegeneration; MJD/SCA31. Introduction
Machado–Joseph disease (MJD/SCA3) is the most common
dominantly inherited cerebellar ataxia worldwide [1]. The dis-
ease is caused by the expansion of a CAG repeat in the coding
region of the gene ATXN3. This gene encodes ataxin-3
(ATXN3), a 42-kDa ubiquitously expressed protein, which
has the polyglutamine tract located in the C-terminal region
[2,3]. The repeat segment that normally consists of 12–44 CAG
is expanded from 61 up to 87 in patients [4]. A striking featureAbbreviations: AMC, 7-amido-4-methylcoumarin; Ub, ubiquitin; UIM,
ubiquitin-interacting motif; UBL, ubiquitin-like protein; UPS, ubiquitin–
proteasome system; Y2H, yeast two-hybrid; SCF, SKP1-Cul-1-F-box protein E3
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doi:10.1016/j.bbamcr.2007.07.012of the polyglutamine diseases is the presence of neuronal
inclusions in the affected brain regions; in MJD, the inclusions
are both nuclear and cytoplasmic and typically ubiquitylated
[5]. These intracellular inclusions contain proteasome subunits
and chaperones, which suggests an attempt of the cell to either
reduce the amount of non-native protein and restore protein
homeostasis or eliminate the inclusions [6]. The physiological
role of ATXN3 is not yet established.
Recently, it was noticed that the Josephin domain of ATXN3
(JD) contains conserved amino acids reminiscent of the
catalytic domain of a member of the deubiquitylating cysteine
protease UCH family (ubiquitin C-terminal hydrolases) [7] and
later, in vitro assays showed that ATXN3 displays Ub hydrolase
activity [8–10]. Strikingly, it was found that ATXN3 suppresses
polyglutamine neurodegeneration in Drosophila, and this
suppressing activity is dependent on its interaction with
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the presence of neural precursor cell expressed developmentally
downregulated gene 8 (NEDD8), an ubiquitin-like protein
(UBL), in Ub-reactive neuronal and glial inclusions of several
neurodegenerative diseases, namely MJD [12]. An active role
was suggested for NEDD8 in the formation of the ubiquitylated
inclusions through the ubiquitin–proteasome system (UPS).
NEDD8 is the UBL with the highest structural homology with
Ub [13] and conjugates to target proteins in a cascade of events
similar to ubiquitylation [14]. So far, NEDD8 has been reported
to conjugate with a limited number of target proteins, including
the cullin family members [15] and p53 [16]. Cullins are the
molecular scaffolds for the assembly of several E3 ubiquitin
ligases, and the best known substrates for NEDD8 conjugation
[15]. Neddylation upregulates the activities of cullin-organized
E3 ubiquitin ligases while conferring intrinsic instability onto
cullins [17]; thus, there is a close link between the ubiquitin and
the NEDD8 pathways. NEDD8 deconjugation is equally
important for the cell and can be carried out by members of
most of the deubiquitylating enzyme (DUB) families UBP/USP
(USP21), JAMM group (CNS/COP9 signalosome) and the
ULP family (NEDP1/SENP8/DEN1) [18].
The fact that ATXN3 interacts with the UBL domain of
HHR23 proteins [19] and the recent finding that NEDD8 is
present in ubiquitylated inclusions in the brain of MJD patients
led us to investigate whether ATXN3 could interact with
NEDD8. In this study, we demonstrate in vitro and in situ that
ATXN3 is able to establish a direct interaction with NEDD8,
through its Josephin domain (JD). Interestingly, the Caenor-
habditis elegans homologue of ATXN3, atx-3, also interacts
with NEDD8, indicating that this protein interaction is
evolutionarily conserved and, thus, of functional relevance.
Furthermore, ATXN3 is able to cleave a fluorogenic substrate,
NEDD8-AMC, which indicates that ATXN3 also has deneddy-
lase activity.2. Materials and methods
2.1. Antibodies
Primary antibody against ataxin-3 variant MJD1-1 (Swiss Prot no. P54252-2
VSP_002784) was raised in rabbits, by immunization with normal full-length
recombinant 6His-ATXN3-var1.1, anti-MJD1.1 (David Biotechnologies). Com-
petition assays were performed to verify the antibody specificity (Fig. S4).
2.2. Yeast two-hybrid assays
The yeast strain Y190 (96400) was purchased from ATCC. The original
vectors pAS1-2 and pACT2 (kindly provided by Dr. S. Elledge, Baylor College
of Medicine) were converted into yeast two-hybrid Gateway® vectors pAS1G
and pACT2G, respectively, following the manufacturer's instructions (Invitro-
gen). The pAS1G-ATXN3 var1.1 coding for normal ATXN3, pAS1G-JD,
pACT2G-JD, pAS1G-NEDD8, pACT2G-NEDD8 plasmids were generated
using the Gateway cloning system®. The pAS1-ATXN3 var2.1 (17Q) (Swiss-
Prot no. P54252) and pAS1-ATXN3-2.1N were prepared using classical cloning
techniques [20]. The yeast transformations were performed using the lithium
acetate method [21]. Transformants of pAS1G-JD, pAS1G-ATXN3 var1.1 or
pAS1-ATXN3-2.1N were grown on SC-WLH supplemented with 130, 140 or
170 mM of amino-1,2,3 triazole (AT), respectively; the remaining were grown
on plates with 20 mM AT. The interaction between SNF1 and SNF4 encoded bypSE1112 and pSE1111, respectively, was used as positive control (kindly
provided by Dr. S. Elledge, Baylor College of Medicine). Incubations were
performed at 30 °C for 5 days. Colony-lift β-galactosidase filter assays were
performed according to the manufacturer's instructions (Clontech).
2.3. Expression plasmids and recombinant proteins
GST-tagged proteins—for the generation of GST-NEDD8 protein, NEDD8
cDNA was amplified from a human brain cDNA library using attB1-NEDD8
(5′-GGGGACAAGTTTGTACAAAAAAGCAGGCTGGATGCTAATTAAAG-
TGAAGAC-3′) and attB2-NEDD8 (5′-GGGGACCACTTTGTACAAGAAA-
GCTGGGTCTCACTGCCTAAGACCACCTC-3′) primers. GST-221cATXN3
expression construct was obtained using pAS1G-ATXN3 var1.1 plasmid as
template and attB1-221cATXN3 (5′-GGGGACAAGTTTGTACAAAAAAGC-
AGGCTGGATGTTAGACGAAGATGAG-3′) and attB2-MJD1.1 (5′-GGGG-
ACCACTTTGTACAAGAAAGCTGGGTCTTATTTTTTTCCTTCTGTTTT-
3′) primers. The cDNA for human HHR23Awas reverse transcribed from total
RNA of HeLa cells extracted with Trizol (Invitrogen) using attB1-HHR23A (5′-
GGGGACAAGTTTGTACAAAAAAGCAGGCTGGATGGCCGTCACCAT-
CACGCTG-3′) and attB2-HHR23A (5′-GGGGACCACTTTGTACAAGAA-
AGCTGGGTCTCACTCGTCATCAAAGTTCTG-3′) primers; gene-specific
sequences are underlined. RT-PCR reactions were performed with Superscript
RT kit (Invitrogen) according to the manufacturer's instructions. The aforemen-
tioned PCR products were first cloned into pDONR201 or pDONR207 vectors
and then transferred to pDEST15 using the Gateway cloning system (Invitrogen)
[22] according to the supplier's instructions.
6His-tagged proteins—the bacterial constructs expressing 6His-tagged
ATXN3-var1.1, 6His-atx-3 and 6His-tagged Josephin domain (JD) were ob-
tained and expressed as described [23]. The 6His-D1 construct (Fig. 2a) was
obtained by introducing a stop codon at position 787 in ATXN3 cDNA using the
QuikChange site-directed mutagenesis kit (Stratagene) and protein expression
was carried out as described [23]. The eukaryotic plasmid 6His-NEDD8 was a
gift from Dr. R. Hay, University of St. Andrews [16].
GFP-tagged constructs—the eukaryotic pEGFP-ATXN3 (28Q) encoding
normal ATXN3 in fusion with GFP (N-terminal) was a gift of Dr. Henry
Paulson, University of Iowa. To obtain the mammalian pEGFP-JD plasmid
encoding the fusion protein GFP-JD, a stop codon was introduced at position
548 in ATXN3 cDNA of the pEGFP-ATXN3 (28Q) using the QuikChange site-
directed mutagenesis kit according to the manufacturer's instructions (Strata-
gene). All clones were confirmed by automated sequencing.
2.4. Purification of recombinant proteins
The expression of GST, GST-NEDD8 was induced in Escherichia coli strain
BL21(DE3) (Invitrogen), whereas GST-221cATXN3 was expressed in BL21
(DE3)pLysS (Invitrogen), all with 1 mM IPTG. GST-HHR23Awas expressed in
BL21(DE3)-SI cells (Invitrogen) using 300 mM NaCl. The bacterial protein
expressions were carried out for 3 h at 30 °C. All GST-tagged proteins were
purified with glutathione-sepharose™ 4B beads (GE Healthcare) according to
the manufacturer's instructions and eluted with 10 mM reduced glutathione in
50 mM Tris–Cl pH 8.
2.5. GST pull-down assay
The purified GST or GST-tagged proteins (2 μg) were incubated rotating for
1 h at 4 °C with 50 μl of glutathione-sepharose™ 4B beads in 500 μl of in vitro
binding buffer (IBB) (50 mM Tris–Cl pH 7.5, 150 mMNaCl, 10% glycerol, 1%
Triton X-100, 1 mM EDTA, 1 mMDTT, 1 mM PMSF [24]). The 6His-J1, 6His-
D1 or 6His-ATXN3-var1.1 was added and incubated for 1–2 h at 4 °C on a
rotator. Incubations of 6His-ATXN3-var1.1, 6His-NEDD8 (UW9225, BioMol)
or 6His-atx-3 were performed with 1% or 3% of BSA, respectively. Bound
fractions were washed with IBB without glycerol and BSA, eluted by boiling in
50 μl of 2× SDS sample buffer and then were analysed by SDS-PAGE.
Immunoblottings were performed using goat anti-GST (1:7500, GE Health-
care), mouse anti-6His (1:2000, Qiagen) or rabbit anti-MJD1.1 (1:25000)
antibodies, all diluted in 1% SM/TBS-T (1% skimmed milk in Tris-buffered
saline 1× (TBS), 0.05% Tween 20), or with rabbit anti-303JSP (1:2000)
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Secondary HRP-coupled antibody incubations were as follows: anti-goat
1:30,000, anti-mouse (Santa Cruz Biotechnology) both at 1:10,000 1% SM/
TBS-T and anti-rabbit (Santa Cruz Biotechnology) 1:25,000 1% SM/TBS-T for
ATXN3-var1.1 or 1:20,000 3% SM/TBS-T for atx-3. Detection was carried out
with ECL (GE Healthcare).
2.6. Cell culture and transfection
HeLa cells were grown (37 °C, 5% CO2) in DMEM (10938, GIBCO)
supplemented with 10% of FBS, 100 U/ml penicillin, 4 mM glutamine and
500 μg/ml streptomycin (Gibco BRL). Cells were transfected at 70% cell
confluence (5 μg of each expression plasmid) using Lipofectamine 2000
(Invitrogen) following the manufacturer's instructions and rinsed with PBS 8 h
later; the DNA concentration was measured by spectrophotometer. Forty-eight
hours after transfection whole cell protein extracts were prepared in 250 μl of
lysis buffer [buffer A (50 mM Tris–HCl pH7.5, 150 mM NaCl, 0.5% Tween
20, 1 mM PMSF) plus 1 mM imidazole] supplemented with EDTA-free
protease inhibitors cocktail (Roche). After sonication lysates were cleared by
centrifugation and incubated with 50 μl of Ni-NTA agarose beads in lysis
buffer. Beads were washed three times with washing buffer (buffer A plus
30 mM imidazole) and bound fractions were eluted with 50 μl of elution buffer
(buffer A plus 500 mM imidazole). Eluted proteins were subjected to SDS-
PAGE and immunoblotted with rabbit anti-GFP antibody at 1:2000 1% SM/
TBS-T overnight, 4 °C. Detection was carried out with ECL detection kit.
2.7. Immunofluorescence and immunoprecipitation
For immunolocalization of endogenous ATXN3 and NEDD8, HEK293
cells were grown on coverslips and were fixed for 20 min in freshly prepared
4% p-formaldehyde (Sigma) in phosphate-buffered saline (PBS), permeabilized
with PBS/0.1% Triton X-100 for 5–7 min, washed in PBS and blocked with
PBS/10% FBS. ATXN3 was detected with anti-SCA3 (1H9 clone, Chemicon)
at 1:500 and NEDD8 was detected with rabbit anti-NEDD8 (PW9340, BioMol)
at 1:50. Fluorescent secondary antibodies (AlexaFluor 488-coupled goat anti-
rabbit and AlexaFluor 568-coupled goat anti-mouse, Molecular probes) wereFig. 1. ATXN3 interacts with NEDD8 in the yeast two-hybrid system. The schemati
encoding normal ataxin-3 were used: GAL4BD-ATXN3 var1.1 and GAL4BD-ATXN
were also tested: pAS1G-JD encodes GAL4BD fusion to Josephin domain and pA
GAL4BD-NEDD8 (crossed rectangle) and GAL4AD-JD was also tested; the filled rh
when growth on nutritional selection plates was observed and colonies stained blue whused at 1:1500. DNA was stained with Dapi (Sigma). Images captured were
then prepared and analysed using Photoshop 5.0LE (Adobe). For immunopre-
cipitation, HEK293 cells (CRL-1573, ATCC) were transfected with 10 μg of
GFP-NEDD8 using Lipofectamine 2000 reagent (Invitrogen) following the
manufacturer's instructions; cells were collected 48 h after transfection, lysed in
buffer A plus 1 mM EDTA and protease inhibitors (Roche), briefly sonicated
and cleared by centrifuged. The lysates were then pre-cleared with Protein-G-
Sepharose (GE Healthcare) for 1 h at 4 °C and then incubated with 9 μl of
polyclonal anti-NEDD8 antibody (PW9340) overnight at 4 °C. The
immunocomplexes were precipitated with Protein-G-Sepharose at 4 °C for
2 h; the beads were washed two times with buffer A minus the detergent and
finally eluted with 2× SDS sample buffer. The eluted proteins were analysed by
Western blot with anti-SCA3 (1H9) or anti-GFP.
2.8. Molecular docking prediction
Models of the JD-NEDD8 and of JD–ubiquitin complexes were built by
superimposing the structures of the NED1–NEDD8 complex (PBD ID 1xt9
[26]) and of the UCH-L3 ubiquitin vinylmethylesther complex (PDB ID 1xd3
[27]), respectively, with the JD domain (PDB ID 1yzb [10]) using the DALI
server [28]. The structures superpose with JD with Z-scores of 1.8 and 4.5, and
rmsds of 3.4 and 2.9 Å, respectively. The interface between the two proteins in
the docked complexes was further refined by geometry optimization with CNS
[29]. All images were made with PyMOL (http://pymol.sourceforge.net/).
2.9. NEDD8-AMC cleavage assay
The putative deneddylase activity of the proteins was evaluated using the
fluorogenic substrate NEDD8-AMC, a reagent that allows determination of
NEDD8 C-terminal hydrolase activity, according to a previously described
protocol [30]. Briefly, 300 μl of assay buffer (50 mM HEPES, 0.5 mM EDTA,
pH 7.5, with 0.1 mg/ml BSA and 1 mM DTT) containing 10 μg of ATXN3 or
ATXN3C14A, purified as described [23], was incubated at 37 °C for 30 min.
The reaction was initiated by adding the substrate to a final concentration of
0.5 μM and the proteins' hydrolytic activities were measured as the release of
AMC, after cleavage, for 9 min using a Perkin Elmer LS 50B fluorimeter.c representation depicts all yeast expression plasmids used. Two cDNA variants
3 var2.1, which lacks UIM3. Two constructs comprising fragments of ATXN3
S1-2.1N encodes JD plus functional UIM1. The reverse interaction between
ombus represents the GAL4BD tag. An interaction was considered positive (+)
en tested for β-galactosidase expression (β-Gal assay). 
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3.1. ATXN3 interacts with NEDD8
In order to evaluate if ATXN3 interacts with NEDD8, we
used the yeast two-hybrid system (Y2H) and GST pull-down
assays. For this study, several Y2H constructs of ATXN3 were
made, coding for the entire protein (Gal4BD-ATXN3 var1.1),
the JD (Gal4BD-JD) or the JD plus the first UIM (ubiquitin-
interacting motif) (Gal4BD-2.1N). A second variant of ATXN3,
ATXN3 var2.1, in which UIM3 is absent, was also tested (see
W-S1). The results showed that ATXN3 interacts with NEDD8,
in the Y2H assay (Fig. 1). No difference was observed when
isoform ATXN3 var1.1 or ATXN3 var2.1 was tested, indicating
that the third UIM in ATXN3 does not influence its ability to
interact with NEDD8. To pinpoint the region in ATXN3 res-
ponsible for the interaction with NEDD8, two truncated frag-
ments of ATXN3 were tested (Fig. 1). The results obtained with
the different fragments of ATXN3 showed that the JD is
sufficient to establish the interaction with NEDD8. We tested
also the reverse interaction between GAL4BD-NEDD8 andFig. 2. ATXN3 interacts with NEDD8 in vitro. The GST pull-down assays show
recombinant proteins used in the assays: 6His-ATXN3 var1.1 represents the full-leng
UIMs; 6His-JD comprises only the JD; GST-221cATXN3 comprises all domains of
Expected molecular weights for all proteins are stated (brackets). Purified GST-NEDD
(c); GST-221cATXN3 was incubated with 6His-NEDD8 (f). Interaction between GST
Input lanes show 10% of the 6His-tagged protein used in the assay. NEDD8 pulled-
failed to interact with GST-221cATXN3. GST alone showed no binding in any assaGAL4AD-JD and a positive interaction was observed. Co-
transformations of the bait or prey constructs with the pACT2
and pAS1 Y2H empty vectors, respectively, showed no positive
interactions (Fig. 1). The results obtained with the Y2H analysis
were confirmed using in vitro pull-down assays, by monitoring
the binding of GST-NEDD8 to several 6His-tagged constructs
of ATXN3 (Fig. 2a). As shown in Fig. 2b, full-length ATXN3
interacts in vitro with NEDD8, further indicating that ATXN3
can bind NEDD8 directly. In order to evaluate whether the
interaction between ATXN3 and NEDD8 is evolutionarily con-
served, we tested if the C. elegans atx-3 could also interact with
humanNEDD8. Interestingly, we observed a positive interaction
between human NEDD8 and atx-3 protein (Fig. 2c). The high
degree of JD conservation, despite an overall identity of only
36% between atx-3 and human ATXN3, may explain this direct
interaction (see W-S1). In C. elegans, ned-8 has been shown to
be crucial for nematode development. The absence of ned-
8 resulted in embryonic lethality or severe developmental ab-
normalities [31]. The conservation of the atx-3/NEDD8 inter-
action throughout evolution suggests a biological and functional
relevance for this protein pair. As a control experiment, we testeddirect interaction of ATXN3 with NEDD8. (a) Schematic representation of
th of ataxin-3 variant 1.1 with three UIMs; 6His-D1 comprises the JD plus two
ATXN3 var1.1 except JD, and 6His-atx-3 represents the ataxin-3 of C. elegans.
8 was incubated with ATXN3 full-length (b), 6His-D1 (d), 6His-JD (e) or atx-3
-HHR23A and 6His-ATXN3 was observed under the conditions established (b).
down ATXN3 (b), its fragments 6His-D1 (d) and 6His-JD (e) and atx-3 (c), but
y. Bands identified with cardinals (#) are protein degradation products.
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under the conditions used, we were able to replicate the inter-
action reported before [19]. Our results also suggest that ATXN3
is able to interact more efficiently with NEDD8 and HHR23A,
than with monomeric Ub (Fig. S2), since a higher amount of
GST-Ub was needed to pull-down a quantity of ATXN3 similar
to those obtained with NEDD8 and HHR23A (Fig. 2b, d). We
also mapped the minimum domain required for ATXN3 to
interact with NEDD8 using the pull-down assays. Truncated
fragments of ATXN3 corresponding to the JD plus UIM1 and
UIM2 (6His-D1), the JD alone (6His-JD) or a C-terminal frag-
ment comprising all ATXN3 domains except JD (GST-221c
ATXN3) were produced and assayed for binding to NEDD8.We
did observe interaction between GST-NEDD8 and 6His-D1 or
6His-JD proteins (Fig. 2d, e), but no interaction was observed
between GST-221cATXN3 and 6His-NEDD8. Thus, we con-
clude that the JD of ATXN3 is sufficient and necessary for the
interaction with NEDD8, in agreement with the results obtained
in the Y2H assay (Fig. 1). No interactions between the D1 or JD
fragments of ATXN3 and monomeric Ub were observed in these
in vitro studies (Fig. S2b, c). In control experiments we could not
detect any binding of ATXN3 or its truncated forms to the beads
alone, or to beads containing GST, indicating that the inter-
actions observed with NEDD8 are specific (Fig. 2b–f). TakenFig. 3. Ataxin-3 interacts with NEDD8 in eukaryotic cells. (a) Immunofluorescence a
and NEDD8. Localization of ATXN3 was detected with anti-SCA3 (1H9) antibody
(red); detection of NEDD8 was performed with polyclonal anti-NEDD8 antibody
(green); nuclei were stained with Dapi (Sigma). (b) Schematic representation of
mammalian cell transfection; the expected molecular weight of GFP-JD fusion prot
with NEDD8 in mammalian cells. The 6His-NEDD8 was co-expressed with GFP-J
GFP-JD (lane 7) or GFP alone (lane 8) were used as control assays. Lanes 1–4 were
6His-NEDD8 (black star) was detected by Western blotting using the anti-GFP
immunoprecipitated by GFP-tagged NEDD8. Cells expressing GFP-NEDD8 were
Supernatants were then incubated overnight with anti-NEDD8 antibody (+) or with
PAGE and immunoblotted with anti-SCA3 or anti-GFP antibodies.together, the results obtained, using the Y2H system and GST
pull-down assays, indicate that ATXN3 interacts with NEDD8
through its JD.
3.2. ATXN3 and NEDD8 colocalize and interact in mammalian
cells
The subcellular expression of endogenous ATXN3 and
NEDD8 proteins was determined in HeLa cells, using immu-
nofluorescence analysis. Cells were fixed, permeabilized and
then immunolabelled with anti-SCA3 (1H9 clone) and anti-
NEDD8 (PW9340) antibodies. Both proteins have nuclear and
cytoplasmic diffuse distribution (Fig. 3a). Incubations with
secondary antibodies alone did not produce specific staining
(data not shown). Merged images show colocalization of
ATXN3 and NEDD8, both in the nucleus and cytoplasm, which
is compatible with the possibility that the two proteins are
interacting partners.
In order to investigate whether ATXN3 can bind NEDD8 in
the context of a mammalian cell, the interaction was analysed in
transfected HeLa cells. Briefly, 6His-NEDD8 was co-expressed
either with GFP-JD or GFP alone (Fig. 3b). His-tagged proteins
were purified under non-denaturing conditions, and the purified
samples were subsequently immunoblotted with an anti-GFPnalysis showed nuclear and cytoplasmatic colocalization of endogenous ATXN3
and probed with AlexaFluor 568-coupled goat anti-mouse secondary antibody
and revealed by AlexaFluor 488-coupled goat anti-rabbit fluorescent antibody
the N-terminal GFP-tagged eukaryotic expression plasmid (GFP-JD) used in
ein is stated (brackets); filled star represents the GFP tag. (c) ATXN3 interacts
D (lanes 1, 5) or empty vector (lanes 2, 6) in HeLa cells. Single expressions of
loaded with 5% of the total protein input of each assay. GFP-JD pulled-down by
antibody (SC-8334, Santa Cruz Biotechnology). (d) Endogenous ATXN3 is
harvested and the supernatants pre-cleared with protein-G-sepharose beads.
out the antibody (−); immunocomplexes were subsequently separated by SDS-
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pEGFP were used as controls. The interaction of 6His-NEDD8
with the JD (Fig. 3c, lane 5) was detected in this assay support-
ing the previous results. No binding of GFP alone to NEDD8
was detected (Fig. 3c, lane 6), indicating that ATXN3 and JD
fusion proteins were specifically co-purified with NEDD8. It
should be noted that the purified proteins detected using the
anti-GFP antibody have molecular sizes corresponding to un-
modified GFP-JD, suggesting that ATXN3 is not neddylated,
but rather that it interacts with NEDD8.
To further confirm the occurrence of this new interaction in
vivo, HEK293 cells were transiently transfected with a constructFig. 4. NEDD8 and ubiquitin share the same binding site on ATXN3 catalytic domai
the electrostatic potential (blue for positive, red for negative). JD is complexed (a) with
b show solid surface representations of NEDD8 and Ub rotated ~90° along the hor
complex. The docking surfaces of NEDD8 and Ub are predominantly basic and com
surface complementarity is notorious in both complexes.expressing GFP-NEDD8. When the cell lysates were incubated
with polyclonal anti-NEDD8 we were able to co-immunopre-
cipitate the endogenous ATXN3 (Fig. 3d). No ATXN3 was
detected in the negative control (omission of the anti-NEDD8
antibody). An immunoblot assay with anti-GFP confirmed that
GFP-NEDD8 protein was efficiently immunoprecipitated
(Fig. 3d). Altogether, these results suggest that endogenous
ATXN3 specifically interacts with NEDD8.
Costa et al. [32] reported the expression pattern of murine
ATXN3, which is expressed ubiquitously since early embryonic
stages, at least in E11.5. Interestingly, previous mRNA studies
showed that the highest expression of the NEDD8 messagen. Solid surface representation of the JD, NEDD8 and Ub coloured according to
NEDD8 (green) and (b) with Ub (violet). The pictures on the left of panels a and
izontal axis in the figure plane, in comparison with their position in the docked
plement the acidic character of the substrate-binding cleft of the JD. The overall
Fig. 5. Hydrolysis of NEDD8-AMC by ATXN3 requires the C14 residue.
ATXN3 displays C-terminal hydrolase activity against NEDD8-AMC (Boston
Biochemicals). Recombinant ATXN3 or mutant ATXN3 (ATXN3C14A) was
incubated with NEDD8-AMC (7-amido-4-methylcoumarin) for a total of 9 min,
and their deneddylase activities measured from the AMC release extent, after
cleavage. No cleavage was observed when only the assay buffer was present
(grey line) or the mutant ATXN3C14A (orange line). However, when ATXN3
was present in the reaction a time-dependent release of AMC could be observed
(blue line) indicating the hydrolytic activity of ATXN3 on NEDD8-AMC. The
slope for the ATXN3 andATXN3C14A activities were 0.037 s−1 and 0.0032 s−1,
respectively.
1625A. Ferro et al. / Biochimica et Biophysica Acta 1773 (2007) 1619–1627occurs at the E11 stage; moreover, Kamitani et al. [33] have
proposed that proteins expressed in the heart and skeletal
muscle or in early development would be good candidates
for NEDD8 interaction. Strikingly, mouse ATXN3 shows pro-
minent expression in these particular tissues [32]. All these data
support a biological relevance for the ATXN3/NEDD8
interaction, not only in differentiated tissues, but also since
early stages of development.
3.3. NEDD8 interacts with ATXN3 in a substrate-like mode
Recently, the structure of JD of ATXN3 has been determined
by NMR [10,34], revealing that it shares a significant structural
homology with the DUB enzymes, human UCH-L3 [27] and
yeast YUH1 [35]. Those studies allowed mapping of the active
site (Q9, C14, H119, N134) and revealed that the binding site
for the N-terminal UBL domain of HHR23B is comprised of an
hydrophobic surface located opposite to the catalytic site of the
JD [10]. The binding site of Ub as a substrate has been pro-
posed to be located just above the active site, in a cleft bordered
by the central catalytic subdomain and by a flexible helical
hairpin that is likely to move to better accommodate the sub-
strate [10,34]. Our data show that ATXN3 interacts specifically
with NEDD8, and that the interaction site involves its catalytic
JD. The high sequence and structural similarity between
NEDD8, Ub and the UBL domain of HHR23B raises two
possible scenarios: (i) NEDD8 could interact with ATXN3 JD
via its exposed hydrophobic surface used for the HHR23B
interaction [10] or (ii) NEDD8 could interact with ATXN3 in a
substrate-like mode, meaning that ATXN3 could have dened-
dylase activity.
We have analysed the surface distribution of conserved and
divergent residues between the UBL domain of HHR23B and
NEDD8, and between Ub and NEDD8, in an effort to identify
the structural basis of their differential binding to ATXN3.
The hydrophobic HHR23B-UBL surface relevant for the
interaction with the JD is not strictly conserved in NEDD8
and we can predict that the NEDD8 interaction site on the JD is
likely to be different. We predict that NEDD8 interacts with the
JD in a substrate-like manner. Our docking model of Ub and
NEDD8 at the putative substrate-binding site of the JD was
built based on the structural homology between Ub/NEDD8
hydrolases and JD. For both complexes the C-terminus-GG76
motif, common to NEDD8 and Ub, is bound deep in the
narrow catalytic canyon, close to the catalytic C14 of ATXN3
(Fig. 4). Accommodation of either NEDD8 or Ub involves
small structural changes both in the JD and in the docked
molecules (data not shown), in regions that have been shown,
by chemical shift perturbation, to be relevant for the JD–
ubiquitin interaction [34]. In these models, the negative
electrostatic surface potential of the JD is complemented by
the positive charge of the docked molecules (Fig. 4a and b) and
docking is further aided by surface complementarity. Our
modelling studies clearly show that both NEDD8 and Ub
should bind in a substrate-like mode. In agreement, ATXN3
has NEDD8 C-terminal hydrolase activity against the fluoro-
genic substrate NEDD8-AMC (7-amido-4-methylcoumarin)(Fig. 5). Furthermore, our results clearly show that the
deneddylase activity of ATXN3 is dependent on the cysteine
at position 14. The mutant ATXN3 (C14A) does not show
deneddylase activity against NEDD8-AMC (Fig. 5). However,
this activity loss is not due to loss of interaction between these
proteins since NEDD8 is still able to interact with mutant
ATXN3 JD(C14A) (see Fig. S3).
In conclusion, in this study, we identified a novel molecular
partner of ATXN3, NEDD8. We demonstrated that the inter-
action between NEDD8 and ATXN3 is specific and indepen-
dent of the presence of the UIM domains and the
polyglutamine tract, since it occurs through its JD. In contrast,
interaction with monomeric Ub is weaker and it requires the
full-length protein. The specific interaction between the JD and
NEDD8 prompted us to build a theoretical model of the
complex, which shows that monomeric Ub and NEDD8 could
share the same binding site. Moreover, we show that ATXN3
has a deneddylase activity dependent on the cysteine residue at
position 14.
The NEDD8 protein is essential for the activity of SCF-like
ubiquitin ligase complexes. These complexes determine the
degradation of several substrates and consequently pace the
pathways in which they participate. Our group has recently
reported a transcriptomic analysis of atx-3 knockout C. elegans
strains [25] where we showed downregulation of several genes
encoding subunits of the SCF complex. Additionally, a recent
analysis of genetic interactions in C. elegans by Zhong and
Sternberg [36] pinpointed several genes encoding UPS-related
proteins and components of SCF-like complexes as genetic
interactors of atx-3 in the worm. Together with these results, the
identification of NEDD8 as a new ATXN3 interacting protein
adds a new perspective to the possible physiological role of
ATXN3 modulating the activity of the UPS.
1626 A. Ferro et al. / Biochimica et Biophysica Acta 1773 (2007) 1619–1627Further studies will be needed to explore the nature and
specificity determinants of this newly identified interaction,
to clarify its physiological role and the biological relevance
of the putative deneddylase activity of ATXN3.
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